Annunziata M, Granata R, Ghigo E. 2011. The IGF system. Acta Diabetol 48:1–9.
Argente J, Barrios V, Pozo J, Munoz M, Hervas F, Stene M, Hernandez M. 1993. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age-and sex-related changes. J Clin Endocrinol Metab 77:1522–1528.
Baker J, Liu JP, Robertson EJ, Efstratiadis A. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73–82.
Bale LK, Conover CA. 1992. Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I. Endocrinology 131:608–614.
Cha BH, Kim BK, Hwang S, Yang BC, Im GS, Park MR, Woo JS, Kim MJ, Seong HH, Cho JH. 2010. Imprinted gene mRNA expression during porcine peri-implantation development. Asian-Aust J Anim Sci 23:693–699.
Chaillet JR. 1994. Genomic imprinting: lessons from mouse transgenes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 307:441–449.
Cheng R, Chang KM, Wu JL. 2002. Different temporal expressions of Tilapia (oreochromis mossambicus) insulin-like growth factor-I and IGF binding protein-3 after growth hormone induction. Mar Biotechnol 4:218–225.
Christoforidis A, Maniadaki I, Stanhope R. 2005. Growth hormone/insulin-like growth factor-1 axis during puberty. Pediatr Endocrinol Rev 3:5–10.
Clemmons DR. 1997. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8:45–62.
Collett-Solberg P, Cohen P. 2000. Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 12:121–136.
Curley JP, Keverne EB. 2004. Imprinting and behavior Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics. John Wiley & Sons, Ltd.
De Pablo F, Robcis HL, Caldes T, Alemany J, Scavo L, Serrano J. 1991. Insulin-like growth factor-I and insulin as growth and differentiation factors in chicken embryogenesis. Poult Sci 70:1790–1796.
DeChiara TM, Efstratiadis A, Robertsen EJ. 1990. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78–80.
Desbois-Mouthon C, Wendum D, Cadoret A, Rey C, Leneuve P, Blaise A, Housset C, Tronche F, Le Bouc Y, Holzenberger M. 2006. Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout. FASEB J 20:773–775.
Eigenmann JE, Amador A, Patterson DF. 1988. Insulin-like growth factor I levels in proportionate dogs, chondrodystrophic dogs and in giant dogs. Acta Endocrinol (Copenh) 118:105–108.
Froesch E, Schmid C, Schwander J, Zapf J. 1985. Actions of insulin-like growth factors. Annu Rev Physiol 47:443–467.
Gerrard D, Okamura C, Ranalletta M, Grant A. 1998. Developmental expression and location of IGF-I and IGF-II mRNA and protein in skeletal muscle. J Anim Sci 76:1004–1011.
Haig D. 2004. Genomic imprinting and kinship: how good is the evidence? Annu Rev Genet 38:553–585.
Haig D, Graham C. 1991. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 64:1045–1046.
Heyner S, Farber M, Rosenblum I. 1990. The insulin family of peptides in early mammalian development. Curr Top Dev Biol 24:137–159.
Hiney JK, Ojeda S, Dees WL. 1991. Insulin-like growth factor I: a possible metabolic signal involved in the regulation of female puberty. Neuroendocrinology 54:420–423.
Jǿrgensen HL. 2003. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Ugeskr L Ger 165:3429.
Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34.
Killian JK, Byrd JC, Jirtle JV, Munday BL, Stoskopf MK, MacDonald RG, Jirtle RL. 2000. M6P/IGF2R imprinting evolution in mammals. Mol Cell 5:707–716.
Killian JK, Nolan CM, Wylie AA, Li T, Vu TH, Hoffman AR, Jirtle RL. 2001. Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Hum Mol Genet 10:1721–1728.
Krassas G, Pontikides N, Kaltsas T, Dumas A, Frystyk J, Chen J, Flyvbjerg A. 2003. Free and total insulin-like growth factor (IGF)-I,-II, and IGF binding protein-1,-2, and-3 serum levels in patients with active thyroid eye disease. J Clin Endocrinol Metab 88:132–135.
Lackey BR, Gray SL, Henricks DM. 1999. The insulin-like growth factor (IGF) system and gonadotropin regulation: actions and interactions. Cytokine Growth Factor Rev 10:201–217.
Laron Z, Klinger B. 1998. Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance). Eur J Endocrinol 138:176–180.
Lau M, Stewart C, Liu Z, Bhatt H, Rotwein P, Stewart CL. 1994. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8:2953–2963.
Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. 2001. The somatomedin hypothesis: 2001. Endocr Rev 22:53–74.
LeRoith D. 2008. Clinical relevance of systemic and local IGF-I: lessons from animal models. Pediatr Endocrinol Rev 5:739–743.
Levitt Katz LE, Rosenfeld RG, Cohen SP. 1995. Clinical significance of insulin-like growth factor binding proteins (IGFBPs). Endocrinologist 5:36–43.
Li C, Bin Y, Curchoe C, Yang L, Feng D, Jiang Q, Tian XC, Zhang S. 2008. Genetic imprinting of H19 and IGF2 in domestic pigs (
Sus scrofa). Anim Biotechnol 19:22–27.
Li F, Zhao R, Xu Q, Chen W, Ma Y, Chen J. 2003. Characteristics of testosterone secretion in male Erhualian and Large White pigs in different developmental stages. J Nanjing Agricultural University 26:117–119.
Li S, Yakar S, Brodt P. 2011. Role of the IGF-axis in liver metastasis: experimental and clinical evidence. Brodt P, editorLiver metastasis: biology and clinical management. Springer; Netherlands: p. 233–271.
Lighten AD, Hardy K, Winston RML, Moore GE. 1997. IGF2 is parentally imprinted in human preimplantation embryos. Nat Genet 15:122–123.
Liu JL, Grinberg A, Westphal H, Sauer B, Accili D, Karas M, LeRoith D. 1998. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol 12:1452–1462.
Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (IGF1R). Cell 75:59–72.
Lu F, Jiang Z, Wang X, Luo Y, Li X, Liu H. 2010. Role of the insulin-like growth factor system in epiphyseal cartilage on the development of Langshan and Arbor Acres chickens,
Gallus domesticus. Poult Sci 89:956–965.
Lu F, Wang X, Pan Q, Huang R, Liu H. 2008. Expression of genes involved in the somatotropic, thyrotropic, and corticotropic axes during development of Langshan and Arbor Acres chickens. Poult Sci 87:2087–2097.
Moses AC, Nissley PS, Passamani J, White RM. 1979. Further characterization of growth hormone-dependent somatomedin-binding proteins in rat serum and demonstration of somatomedin-binding proteins produced by rat liver cells in culture. Endocrinology 104:536–546.
Nezer C, Moreau L, Brouwers B, Coppieters W, Detilleux J, Hanset R, Karim L, Kvasz A, Leroy P, Georges M. 1999. An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat Genet 21:155–156.
Pavelic J, Radakovic B, Pavelic K. 2007. Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma. Gynecol Oncol 105:727–735.
Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609–2617.
Rabnott G, Kaye P, Pantaleon M, ericho H. 2003. The role of insulin-like growth factor II and its receptor in mouse preimplantation development. Reprod Fertil Dev 15:37–45.
Rajaram S, Baylink DJ, Mohan S. 1997. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18:801–831.
Rappolee DA, Sturm KS, Behrendtsen O, Schultz GA, Pedersen RA, Werb Z. 1992. Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes Dev 6:939–952.
Ruan W, Powell-Braxton L, Kopchick JJ, Kleinberg DL. 1999. Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development. Endocrinology 140:1984–1989.
Ryan PD, Goss PE. 2008. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist 13:16–24.
Sachdev D, Yee D. 2001. The IGF system and breast cancer. Endocr Relat Cancer 8:197–209.
Skalkidou A, Petridou E, Papathoma E, Salvanos H, Kedikoglou S, Chrousos G, Trichopoulos D. 2003. Determinants and consequences of major insulin-like growth factor components among full-term healthy neonates. Cancer Epidemiol Biomarkers Prev 12:860–865.
Tannenbaum G, Guyda HJ, Posner BI. 1983. Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science 220:77–79.
Tryfonidou M, Holl M, Vastenburg M, Oosterlaken-Dijksterhuis M, Birkenh ger-Frenkel D, Van den Brom W, Hazewinkel H. 2003. Hormonal regulation of calcium homeostasis in two breeds of dogs during growth at different rates. J Anim Sci 81:1568–1580.
Uchijima Y, Takenaka A, Takahashi SI, Noguchi T. 1995. Production of insulin-like growth factors and their binding proteins in primary cultures of rat liver parenchymal and nonparenchymal cells. Biosci Biotechnol Biochem 59:1503–1515.
Wang ZQ, Fung MR, Barlow DP, Wagner EF. 1994. Regulation of embryonic growth and lysosomal targeting by the imprintedIGF2/Mpr gene. Nature 372:464–467.